133 related articles for article (PubMed ID: 11052476)
1. High proliferative activity is associated with dysplasia in ulcerative colitis.
Shinozaki M; Watanabe T; Kubota Y; Sawada T; Nagawa H; Muto T
Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S34-9. PubMed ID: 11052476
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
Sjöqvist U; Ost A; Löfberg R
Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
[TBL] [Abstract][Full Text] [Related]
3. Computer-assisted quantitative analysis of Ki-67 antigen in dysplasia--associated lesions or masses in ulcerative colitis.
Zivković V; Petrović A; Dordević B; Katić V; Gligorijević J; Pavlović V; Krstić M
Vojnosanit Pregl; 2007 Nov; 64(11):753-8. PubMed ID: 18050970
[TBL] [Abstract][Full Text] [Related]
4. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
[TBL] [Abstract][Full Text] [Related]
5. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease.
Kullmann F; Fadaie M; Gross V; Knüchel R; Bocker T; Steinbach P; Schölmerich J; Rüschoff J
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):371-9. PubMed ID: 8781908
[TBL] [Abstract][Full Text] [Related]
6. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.
Andersen SN; Rognum TO; Bakka A; Clausen OP
Mol Pathol; 1998 Dec; 51(6):327-32. PubMed ID: 10193513
[TBL] [Abstract][Full Text] [Related]
7. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
[TBL] [Abstract][Full Text] [Related]
8. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?
Gorfine SR; Bauer JJ; Harris MT; Kreel I
Dis Colon Rectum; 2000 Nov; 43(11):1575-81. PubMed ID: 11089596
[TBL] [Abstract][Full Text] [Related]
9. Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasia.
Agawa S; Muto T; Morioka Y
Dis Colon Rectum; 1988 May; 31(5):387-9. PubMed ID: 2452723
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
Maruyama K; Saigusa N; Baba S; Kino I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
[TBL] [Abstract][Full Text] [Related]
11. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
Stenling R; Lindberg J; Rutegård J; Palmqvist R
APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
14. Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis.
Klepp P; Tollisen A; Røseth A; Cvancarova Småstuen M; Andersen SN; Vatn M; Moum BA; Brackmann S
World J Gastroenterol; 2018 Sep; 24(35):4069-4076. PubMed ID: 30254411
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for carcinoma of the pelvic ileal pouch/anal canal in ulcerative colitis.
Elkowitz D; Daum F; Markowitz J; Proccaccino J; Boas E; Cuomo J; Kahn E
Ann Clin Lab Sci; 2004; 34(2):143-9. PubMed ID: 15228225
[TBL] [Abstract][Full Text] [Related]
16. Study of the cell proliferation kinetics in ulcerative colitis, adenomatous polyps, and cancer.
Kanemitsu T; Koike A; Yamamoto S
Cancer; 1985 Sep; 56(5):1094-8. PubMed ID: 4016699
[TBL] [Abstract][Full Text] [Related]
17. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia.
Frăţilă OC; Iliaş TI
Rom J Morphol Embryol; 2013; 54(1):143-9. PubMed ID: 23529322
[TBL] [Abstract][Full Text] [Related]
18. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.
Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I
Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637
[TBL] [Abstract][Full Text] [Related]
19. Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis.
Ortner MA; Fusco V; Ebert B; Sukowski U; Weber-Eibel J; Fleige B; Stolte M; Oberhuber G; Rinneberg H; Lochs H
Gastrointest Endosc; 2010 Feb; 71(2):312-8. PubMed ID: 20003972
[TBL] [Abstract][Full Text] [Related]
20. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
